LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vaginal Bacteria Linked to Higher HIV Susceptibility

By LabMedica International staff writers
Posted on 07 Feb 2018
Image: Parvimonas, gram-positive cocci, when found in the vagina increase the risk of HIV (Photo courtesy of Erasmus Medical Center).
Image: Parvimonas, gram-positive cocci, when found in the vagina increase the risk of HIV (Photo courtesy of Erasmus Medical Center).
Disruptions of vaginal microbiota might increase women's susceptibility to human immunodeficiency virus (HIV) infection. Advances in molecular microbiology have enabled detailed examination of associations between vaginal bacteria and HIV acquisition.

Most studies of microbes that colonize different parts the body, inside and out, suggest that a greater variety of bacteria in those locations is healthier for the human who harbors them. The greater the diversity of bacteria in a person's microbiota, the better, but earlier studies turned up a surprising exception: the vagina.

Scientists associated with the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) performed a nested case-control study of participants from eastern and southern Africa. Data from five cohorts of African women (female sex workers, pregnant and post-partum women, and women in sero-discordant relationships) were used to form a nested case-control analysis between women who acquired HIV infection versus those who remained seronegative. Deep sequence analysis of broad-range 16S rRNA gene polymerase chain reaction (PCR) products was applied to a subset of 55 cases and 55 controls.

The team identified 87 women who acquired HIV infection (cases) and 262 controls who did not acquire HIV infection, between November, 2004, and August, 2014. Of seven bacterial species linked to higher risk, the most conspicuous of them is Parvimonas Type 1, an otherwise common bacterium, not considered particularly worrisome. Women carrying high concentrations of that Parvimonas Type 1 had much higher odds of 4.6 to one of acquiring HIV than those who did not. Other bacteria linked to the highest increases in risk of HIV infection are: Parvimonas species Types 2, Gemella asaccharolytica, Mycoplasma hominis, Leptotrichia/Sneathia, Eggerthella species Type 1 and vaginal Megasphaera.

The authors concluded that differences in the vaginal microbial diversity and concentrations of key bacteria were associated with greater risk of HIV acquisition in women. Defining vaginal bacterial taxa associated with HIV risk could point to mechanisms that influence HIV susceptibility and provide important targets for future prevention. The study was published on January 25, 2018, in the journal The Lancet Infectious Diseases.

Related Links:
Fred Hutchinson Cancer Research Center

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more